BIOMECHANICAL APPROACH TO THE CLINICAL TREATMENT OF PULMONARY ARTERIAL HYPERTENSION

Negative clinical trend of severe pulmonary arterial hypertension (PAH) is due to right ventricular chamber dilatation and consequent dysfunction. On a biomechanical basis the clinical evolution is associated to a progressive mismatching of the artero-ventricular junction and a possible mechanical intervention may be foreseen. This paper demonstrates how the progressive right ventricular dysfunction, in terms of biochemical–mechanical efficiency, is related to the stress–strain curve of the pulmonary artery, simulated by superimposing different elastance tubes in a cardiovascular mock. Applying the experimental signals to an "ideal" normal and dilated ventricle, it was demonstrated that the very high pulmonary elastance at high pressure is the prime cause of a sharp efficiency drop, in comparison with an aortic similar condition. This evidence supports the proposal of mechanical interventions to reduce pulmonary arterial elastance to improve the artero-ventricular matching, increase the reduced ventricular efficiency and change the negative trend of the illness.

[1]  M. C. Han,et al.  MR imaging of congenitally corrected transposition of the great vessels in adults. , 1989, AJR. American journal of roentgenology.

[2]  L. Howard Prognostic factors in pulmonary arterial hypertension: assessing the course of the disease , 2011, European Respiratory Review.

[3]  R Langer,et al.  Creation of viable pulmonary artery autografts through tissue engineering. , 1998, The Journal of thoracic and cardiovascular surgery.

[4]  M. Humbert,et al.  The study of risk in pulmonary arterial hypertension , 2012, European Respiratory Review.

[5]  K. Shimada,et al.  Long-term survival in aged patients with corrected transposition of the great arteries. , 1992, Chest.

[6]  H. Garnier,et al.  [Corrected transposition of the great vessels in aged adults. Apropos of 2 patients aged 72 and 80]. , 1986, Archives des maladies du coeur et des vaisseaux.

[7]  H. W. Weizsäcker,et al.  Biomechanical behavior of the arterial wall and its numerical characterization , 1998, Comput. Biol. Medicine.

[8]  R Langer,et al.  Functional arteries grown in vitro. , 1999, Science.

[9]  Liang Ge,et al.  Biomechanical comparison of human pulmonary and aortic roots. , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[10]  V. Fuster,et al.  Right ventriculo-arterial coupling in pulmonary hypertension: a magnetic resonance study , 2011, Heart.

[11]  J. Bronzwaer,et al.  Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. , 2007, European heart journal.

[12]  A. M. Bertetto,et al.  One-dimensional experimental mechanical characterisation of porcine aortic root wall , 1999, Medical & Biological Engineering & Computing.

[13]  H. Piene Pulmonary arterial impedance and right ventricular function. , 1986, Physiological reviews.

[14]  M. Humbert,et al.  Pulmonary arterial hypertension: bridging the present to the future , 2012, European Respiratory Review.

[15]  Edward G Lakatta,et al.  Arterial-ventricular coupling: mechanistic insights into cardiovascular performance at rest and during exercise. , 2008, Journal of applied physiology.

[16]  A. Noordegraaf,et al.  The role of the right ventricle in pulmonary arterial hypertension , 2011, European Respiratory Review.

[17]  P. Fourie,et al.  Pulmonary artery compliance: its role in right ventricular-arterial coupling. , 1992, Cardiovascular research.

[18]  B. Strauer,et al.  Left ventricular systolic wall stress as a primary determinant of myocardial oxygen consumption: Comparative studies in patients with normal left ventricular function, with pressure and volume overload and with coronary heart disease , 1977, Basic Research in Cardiology.

[19]  W. Laskey,et al.  Right ventricular-pulmonary arterial interactions , 2006, Annals of Biomedical Engineering.

[20]  A. Cohen-Solal,et al.  Left ventricular‐arterial coupling in systemic hypertension: analysis by means of arterial effective and left ventricular elastances , 1994, Journal of hypertension.

[21]  H. Champion,et al.  Right heart function and haemodynamics in pulmonary hypertension , 2008, International journal of clinical practice. Supplement.

[22]  D. Mccrory,et al.  Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. , 2004, Chest.

[23]  B. Brundage,et al.  Tadalafil for the treatment of pulmonary arterial hypertension: a double-blind 52-week uncontrolled extension study. , 2012, Journal of the American College of Cardiology.